Search Results - "Contasta, Ida"

Refine Results
  1. 1

    A gender-related action of IFNbeta-therapy was found in multiple sclerosis by Contasta, Ida, Totaro, Rocco, Pellegrini, Patrizia, Del Beato, Tiziana, Carolei, Antonio, Berghella, Anna Maria

    Published in Journal of translational medicine (14-11-2012)
    “…Understanding how sexual dimorphism affects the physiological and pathological responses of the immune system is of considerable clinical importance and could…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer by Pellegrini, Patrizia, Contasta, Ida, Del Beato, Tiziana, Ciccone, Fabiana, Berghella, Anna Maria

    Published in Clinical & developmental immunology (01-01-2011)
    “…Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences…”
    Get full text
    Journal Article
  5. 5

    The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy by Berghella, Anna Maria, Pellegrini, Patrizia, Del Beato, Tiziana, Ciccone, Fabiana, Contasta, Ida

    Published in Cancer Immunology, Immunotherapy (01-10-2011)
    “…Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical…”
    Get full text
    Journal Article
  6. 6
  7. 7

    CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response by Pellegrini, Patrizia, Berghella, Anna Maria, Contasta, Ida, Adorno, Domenico

    Published in Transplant immunology (01-10-2003)
    “…Understanding the physiological role of CD30 would be an important step forward in transplants because CD30 + T cells can be induced by alloantigens even in…”
    Get full text
    Journal Article
  8. 8

    Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer by Ciccone, Fabiana, Del Beato, Tiziana, Contasta, Ida, Pellegrini, Patrizia, Berghella, Anna Maria

    Published in Journal of immunology research (2010)
    “…Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences…”
    Get full text
    Journal Article
  9. 9

    The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer by Pellegrini, Patrizia, Berghella, Anna Maria, Contasta, Ida, Del Beato, Tiziana, Adorno, Domenico

    Published in Cancer biotherapy & radiopharmaceuticals (01-10-2006)
    “…Therapy, and, therefore, prognosis, is strictly related to cancer stage, and hence, screening tests that can contribute to the early classification of disease…”
    Get more information
    Journal Article
  10. 10

    Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? by Berghella, Anna Maria, Contasta, Ida, Pellegrini, Patrizia, Del Beato, Tiziana, Adorno, Domenico

    Published in Cancer biotherapy & radiopharmaceuticals (01-10-2006)
    “…This paper focuses on our data on colon cancer patients. Our overall results lead us to believe that the suppressive effect of specific cytokines in colon…”
    Get more information
    Journal Article
  11. 11

    Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions by Contasta, Ida, Berghella, Anna Maria, Pellegrini, Patrizia, Adorno, Domenico

    Published in Cancer biotherapy & radiopharmaceuticals (01-08-2003)
    “…The pathogenesis of cancer is currently under intensive investigation to identify reliable prognostic indices for the early detection of disease. Adenomas have…”
    Get more information
    Journal Article
  12. 12

    Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy by Contasta, Ida, Pellegrini, Patrizia, Berghella, Anna Maria, Del Beato, Tiziana, Adorno, Domenico

    Published in Cancer biotherapy & radiopharmaceuticals (01-10-2006)
    “…Studies have shown that changes occur in c-Ki-ras, p53, and Bcl2 gene structure and function during the various stages of human colon carcinogenesis…”
    Get more information
    Journal Article
  13. 13

    IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effects by Pellegrini, Patrizia, Totaro, Rocco, Contasta, Ida, Berghella, Anna Maria, Russo, Tomassina, Carolei, Antonio, Adorno, Domenico

    Published in Clinical neuropharmacology (01-11-2004)
    “…The authors evaluated the relationships between clinical and pharmacologic parameters and the Th1/Th2/Th3 cytokine network in patients with relapsing-remitting…”
    Get full text
    Journal Article
  14. 14

    Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer by PELLEGRINI, P, CONTASTA, I, BERGHELLA, A. M, GARGANO, E, MAMMARELLA, C, ADORNO, D

    Published in Cancer Immunology, Immunotherapy (01-09-2000)
    “…Matrix metalloproteinases (MMP) are members of a multigene family of zinc-dependent enzymes involved in the degradation of extracellular matrix components…”
    Get full text
    Journal Article
  15. 15

    Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy by Berghella, Anna Maria, Totaro, Rocco, Pellegrini, Patrizia, Contasta, Ida, Russo, Tomassina, Carolei, Antonio, Adorno, Domenico

    Published in Neuroimmunomodulation (2005)
    “…A comparative immunological evaluation of multiple sclerosis (MS) patients receiving IFNbeta treatment and patients who are not receiving treatment may help…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer by Berghella, Anna Maria, Contasta, Ida, Pellegrini, Patrizia, Del Beato, Tiziana, Adorno, Domenico

    Published in Cancer biotherapy & radiopharmaceuticals (01-02-2002)
    “…In cancer, the extent to which the disease has spread is probably the most important factor in determining patient prognosis. Hence practical and non-invasive…”
    Get more information
    Journal Article
  18. 18

    IFN??-1a Treatment and Reestablishment of Th1 Regulation in MS Patients: Dose Effects by Pellegrini, Patrizia, Totaro, Rocco, Contasta, Ida, Berghella, Anna Maria, Russo, Tomassina, Carolei, Antonio, Adorno, Domenico

    Published in Clinical neuropharmacology (01-12-2004)
    “…The authors evaluated the relationships between clinical and pharmacologic parameters and the Th1/Th2/Th3 cytokine network in patients with relapsing-remitting…”
    Get full text
    Journal Article
  19. 19

    Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules by Contasta, I, Pellegrini, P, Berghella, A M, Adorno, D

    Published in Cancer biotherapy & radiopharmaceuticals (01-02-2001)
    “…Cytokine regulation of lymphocyte survival may play an important role in the control of the cell cycle during the immune response both in health and disease…”
    Get more information
    Journal Article
  20. 20

    Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network by Contasta, I, Berghella, A M, Pellegrini, P, Del Beato, T, Casciani, C A, Adorno, D

    Published in Cancer biotherapy & radiopharmaceuticals (01-12-1999)
    “…The evaluation of the balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) would appear to be important in…”
    Get more information
    Journal Article